News & Updates

Among pregnant women, exposure to mRNA COVID-19 vaccine in the first trimester does not appear to contribute to an increased risk of selected major structural birth defects, according to a retrospective study.

Immunization with the non-live recombinant zoster vaccine (RZV) or live-attenuated zoster vaccine (ZVL) is associated with reductions in the risk of dementia relative to the 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a large observational study in adults aged ≥50 years.

The use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) during pregnancy appears to be safe and well tolerated in cisgender women, according to the initial data of HPTN* 084 open-label extension (OLE) study presented at AIDS 2024.

In preterm infants, the use of multistrain probiotics does not appear to prevent colonization with multidrug-resistant organisms or highly epidemic bacteria (MDRO+), as shown in the phase III PRIMAL* trial.

A pharmacy-specific, foundational HIV management education package can help improve pharmacist knowledge in HIV management and self-reported confidence in managing this specialty area, suggests a recent study.

A new patient achieves sustained HIV remission – the seventh in the world – following stem cell therapy for blood cancer and after stopping antiretroviral therapy (ART), adding to the roster of individuals with HIV who are inching their way towards a potential cure.

Pre-exposure prophylaxis (PrEP) with the antibiotic doxycycline helps to prevent sexually transmitted infections (STIs) in high-risk populations, including female sex workers and HIV-positive men who have sex with men (MSM), according to two small studies.